Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Shen

Showing results (191-200 of 203) with videos related to

Pageof 21
Sort By:
Nature Medicine|July 12, 2024
Author Correction: Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosisFeng Mei, Stephen P J Fancy, Yun-An A Shen, et al.
Nature Medicine|July 7, 2014
Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosisFeng Mei, Stephen P J Fancy, Yun-An A Shen, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2011
Neurite outgrowth inhibitor Nogo-A establishes spatial segregation and extent of oligodendrocyte myelinationS Y Christin Chong, Sheila S Rosenberg, Stephen P J Fancy, et al.
Cell Reports|August 24, 2022
Disease-associated oligodendrocyte responses across neurodegenerative diseasesShristi Pandey, Kimberle Shen, Seung-Hye Lee, et al.
Brain : a Journal of Neurology|December 16, 2017
Clemastine rescues myelination defects and promotes functional recovery in hypoxic brain injuryBruce A C Cree, Jianqin Niu, Kimberly K Hoi, et al.
Leukemia|July 1, 2017
BET protein proteolysis targeting chimera (PROTAC) exerts potent lethal activity against mantle cell lymphoma cellsB Sun, W Fiskus, Y Qian, et al.
Elife|September 28, 2016
Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recoveryFeng Mei, Klaus Lehmann-Horn, Yun-An A Shen, et al.
Leukemia|January 3, 2017
Novel BET protein proteolysis-targeting chimera exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm secondary (s) AML cellsD T Saenz, W Fiskus, Y Qian, et al.
Communications Biology|April 9, 2025
Characterization of exoribonuclease XRN1 as a cancer target and identification of adenosine-3',5'-bisphosphate as a potent enzyme inhibitorGordon J Lockbaum, Maureen M Lynes, Sophie A Shen, et al.
Molecular Systems Biology|April 4, 2013
SH3 interactome conserves general function over specific formXiaofeng Xin, David Gfeller, Jackie Cheng, et al.
Pageof 21

Showing results (191-200 of 203) with videos related to

Sort By:
Pageof 21
Nature Medicine|July 12, 2024
Author Correction: Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosisFeng Mei, Stephen P J Fancy, Yun-An A Shen, et al.
Nature Medicine|July 7, 2014
Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosisFeng Mei, Stephen P J Fancy, Yun-An A Shen, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2011
Neurite outgrowth inhibitor Nogo-A establishes spatial segregation and extent of oligodendrocyte myelinationS Y Christin Chong, Sheila S Rosenberg, Stephen P J Fancy, et al.
Cell Reports|August 24, 2022
Disease-associated oligodendrocyte responses across neurodegenerative diseasesShristi Pandey, Kimberle Shen, Seung-Hye Lee, et al.
Brain : a Journal of Neurology|December 16, 2017
Clemastine rescues myelination defects and promotes functional recovery in hypoxic brain injuryBruce A C Cree, Jianqin Niu, Kimberly K Hoi, et al.
Leukemia|July 1, 2017
BET protein proteolysis targeting chimera (PROTAC) exerts potent lethal activity against mantle cell lymphoma cellsB Sun, W Fiskus, Y Qian, et al.
Elife|September 28, 2016
Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recoveryFeng Mei, Klaus Lehmann-Horn, Yun-An A Shen, et al.
Leukemia|January 3, 2017
Novel BET protein proteolysis-targeting chimera exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm secondary (s) AML cellsD T Saenz, W Fiskus, Y Qian, et al.
Communications Biology|April 9, 2025
Characterization of exoribonuclease XRN1 as a cancer target and identification of adenosine-3',5'-bisphosphate as a potent enzyme inhibitorGordon J Lockbaum, Maureen M Lynes, Sophie A Shen, et al.
Molecular Systems Biology|April 4, 2013
SH3 interactome conserves general function over specific formXiaofeng Xin, David Gfeller, Jackie Cheng, et al.
Pageof 21